OliX Pharmaceuticals, Inc (226950.KQ) — Stock Score Summary

OliX Pharmaceuticals, Inc (226950.KQ) has a MoatMap StockRank of 24/100 based on Quality (36/100), Value (35/100), and Momentum (39/100) factor scores. The current signal is SELL. OliX Pharmaceuticals is a clinical-stage biotech company. It lacks the commercialized product portfolio, recurring revenues, and validated CDMO pricing power required to fit our quality investment criteria.

OliX Pharmaceuticals, Inc. is a clinical-stage biotechnology company developing therapeutics based on its proprietary RNA interference (RNAi) platform technology. The company's asymmetric siRNA (asiRNA) platform serves as a key competitive moat, minimizing off-target side effects compared to traditional RNAi therapies. OliX is a niche player focusing on unmet medical needs in ophthalmology, dermatology, and oncology.

Key Financial Metrics

Price$79.91
Market Cap$2.3B
P/E (Forward)-118.47
Price/Book16.35
Return on Invested Capital-6.6%
Debt/Equity14.99
Gross Margin52.3%
Operating Margin-301.9%
Revenue Growth265.8%

OliX Pharmaceuticals, Inc operates in the Biotechnology industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is OliX Pharmaceuticals, Inc’s (226950.KQ) StockRank?
MoatMap’s StockRank for OliX Pharmaceuticals, Inc (226950.KQ) is 24/100, with a Sell signal. It is a composite of Quality (36), Value (35), and Momentum (39) factor ranks across MoatMap’s 19,000+ stock universe.
Does OliX Pharmaceuticals, Inc have an economic moat?
OliX Pharmaceuticals, Inc (226950.KQ) has a Quality factor score of 36/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is OliX Pharmaceuticals, Inc a buy, hold, or sell?
MoatMap’s current signal for OliX Pharmaceuticals, Inc (226950.KQ) is Sell, based on a StockRank of 24/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is OliX Pharmaceuticals, Inc in?
OliX Pharmaceuticals, Inc (226950.KQ) operates in the Healthcare sector, specifically the Biotechnology industry (South Korea).
Browse all ranked stocks226950.KQ deep dive reportAI ChampionsHow we score stocksSense-check another stock